BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 38717360)

  • 1. An emerging strategy: probiotics enhance the effectiveness of tumor immunotherapy via mediating the gut microbiome.
    Jiang S; Ma W; Ma C; Zhang Z; Zhang W; Zhang J
    Gut Microbes; 2024; 16(1):2341717. PubMed ID: 38717360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the gut microbiota in tumor, immunity, and immunotherapy.
    Xie Y; Liu F
    Front Immunol; 2024; 15():1410928. PubMed ID: 38903520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel strategies for modulating the gut microbiome for cancer therapy.
    Cho YS; Han K; Xu J; Moon JJ
    Adv Drug Deliv Rev; 2024 Jul; 210():115332. PubMed ID: 38759702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbial metabolites affect tumor progression, immunity and therapy prediction by reshaping the tumor microenvironment (Review).
    Zhou Y; Han W; Feng Y; Wang Y; Sun T; Xu J
    Int J Oncol; 2024 Jul; 65(1):. PubMed ID: 38847233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbes in the tumor microenvironment: New additions to break the tumor immunotherapy dilemma.
    Zhou L; Fan S; Zhang W; Wang D; Tang D
    Microbiol Res; 2024 Aug; 285():127777. PubMed ID: 38797111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revealing the therapeutic properties of gut microbiota: transforming cancer immunotherapy from basic to clinical approaches.
    Hazra R; Chattopadhyay S; Mallick A; Gayen S; Roy S
    Med Oncol; 2024 Jun; 41(7):175. PubMed ID: 38874788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiome as a treatment in colorectal cancer.
    Khan M; Shah S; Shah W; Khan I; Ali H; Ali I; Ullah R; Wang X; Mehmood A; Wang Y
    Int Rev Immunol; 2024; 43(4):229-247. PubMed ID: 38343353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical role of the gut microbiota in immune responses and cancer immunotherapy.
    Li Z; Xiong W; Liang Z; Wang J; Zeng Z; Kołat D; Li X; Zhou D; Xu X; Zhao L
    J Hematol Oncol; 2024 May; 17(1):33. PubMed ID: 38745196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Applications of the Gut Microbiome in Genitourinary Cancers.
    Nguyen CB; Vaishampayan UN
    Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e100041. PubMed ID: 38788173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the microbiota in response to and recovery from cancer therapy.
    Blake SJ; Wolf Y; Boursi B; Lynn DJ
    Nat Rev Immunol; 2024 May; 24(5):308-325. PubMed ID: 37932511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the microscopic world: Exploring the role and potential of intratumoral microbiota in cancer immunotherapy.
    Zhang L; Yu L
    Medicine (Baltimore); 2024 May; 103(20):e38078. PubMed ID: 38758914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of microbiota, mucosal malignancies, and immunotherapy-Mechanistic insights.
    Mager LF; Krause T; McCoy KD
    Mucosal Immunol; 2024 Jun; 17(3):402-415. PubMed ID: 38521413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiome ecological topology as next-generation biomarkers for cancer immunotherapy.
    Ning L; Hong J
    Cell; 2024 Jun; 187(13):3231-3232. PubMed ID: 38906099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eating away cancer: the potential of diet and the microbiome for shaping immunotherapy outcome.
    Nguyen NA; Jiang Y; McQuade JL
    Front Immunol; 2024; 15():1409414. PubMed ID: 38873602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiome and cancer: from mechanistic implications in disease progression and treatment to development of novel antitumoral strategies.
    Constantin M; Chifiriuc MC; Mihaescu G; Corcionivoschi N; Burlibasa L; Bleotu C; Tudorache S; Mitache MM; Filip R; Munteanu SG; Gradisteanu Pircalabioru G
    Front Immunol; 2024; 15():1373504. PubMed ID: 38715617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Influence of Liver Cirrhosis, Additional Probiotics, and Alcohol Consumption on Hepatic Fibrosis and the Gut Microbiota Deserves Attention.
    Du F; Tao L
    J Nutr; 2024 Jun; 154(6):1959. PubMed ID: 38599387
    [No Abstract]   [Full Text] [Related]  

  • 17. Sex differences in cancer and immunotherapy outcomes: the role of androgen receptor.
    Zhao J; Wang Q; Tan AF; Loh CJL; Toh HC
    Front Immunol; 2024; 15():1416941. PubMed ID: 38863718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer and the microbiota.
    Garrett WS
    Science; 2015 Apr; 348(6230):80-6. PubMed ID: 25838377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resident Microbiome of Kidney Tumors.
    Kovaleva O; Podlesnaya P; Gratchev A
    Oncol Rev; 2024; 18():1393664. PubMed ID: 38835643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulating commensal bacteria to intervene in cancer immunotherapy.
    Jia D; Wang L
    Clin Transl Med; 2024 May; 14(5):e1704. PubMed ID: 38778442
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.